Maze Therapeutics, Inc. Common Stock (MAZE) — Cash Flow Quality Index
Maze Therapeutics, Inc. Common Stock (MAZE) has a Cash Flow Quality Index of 1.04x as of June 2024. Operating cash flow of $145.05 Million exceeds net income of $139.06 Million, indicating high earnings quality where cash backs reported profits. Explore MAZE operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Maze Therapeutics, Inc. Common Stock Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Maze Therapeutics, Inc. Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see MAZE operating cash flow.
Annual Cash Flow Quality Index for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year earnings quality comparison for Maze Therapeutics, Inc. Common Stock.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.45x | $75.95 Million | $52.23 Million | — |